BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21434574)

  • 1. Improvement of dissolution properties of lamotrigine by inclusion complexation and solid dispersion technique.
    Parmar Komal R; Satapara Vijay P; Shah Sunny R; Sheth Navin R
    Pharmazie; 2011 Feb; 66(2):119-23. PubMed ID: 21434574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.
    Shinde VR; Shelake MR; Shetty SS; Chavan-Patil AB; Pore YV; Late SG
    J Pharm Pharmacol; 2008 Sep; 60(9):1121-9. PubMed ID: 18718114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.
    Zhao X; Liu X; Gan L; Zhou C; Mo J
    Arch Pharm Res; 2011 Jun; 34(6):949-59. PubMed ID: 21725816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M; Maestrelli F; Bragagni M; Mura P
    J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclodextrin and phospholipid complexation in solubility and dissolution enhancement: a critical and meta-analysis.
    Semalty A
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1255-72. PubMed ID: 24909802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characterization of solid dispersions of three antiepileptic drugs prepared by solvent evaporation method.
    Douroumis D; Bouropoulos N; Fahr A
    J Pharm Pharmacol; 2007 May; 59(5):645-53. PubMed ID: 17524229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, characterization and tableting of cilnidipine solid dispersions.
    Hu L; Song W; Niu F; Jiao K; Jia Z
    Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of dissolution profile by solid dispersion (kneading) technique.
    Modi A; Tayade P
    AAPS PharmSciTech; 2006 Aug; 7(3):68. PubMed ID: 17025249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement on dissolution rate of inclusion complex of Rifabutin drug with β-cyclodextrin.
    Shanmuga Priya A; Sivakamavalli J; Vaseeharan B; Stalin T
    Int J Biol Macromol; 2013 Nov; 62():472-80. PubMed ID: 24076034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubility and stability enhancement of atorvastatin by cyclodextrin complexation.
    Palem CR; Patel S; Pokharkar VB
    PDA J Pharm Sci Technol; 2009; 63(3):217-25. PubMed ID: 20069794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In sight into tadalafil - block copolymer binary solid dispersion: Mechanistic investigation of dissolution enhancement.
    Mehanna MM; Motawaa AM; Samaha MW
    Int J Pharm; 2010 Dec; 402(1-2):78-88. PubMed ID: 20933589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of a fenofibrate-hydroxypropyl-beta-cyclodextrin system prepared by a co-grinding method.
    Gu FG; Wang Y; Meng GD; Han HB; Wu CZ
    Pharmazie; 2012 Feb; 67(2):143-6. PubMed ID: 22512084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
    Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
    Ozdemir N; Ordu S
    Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
    Patil AL; Pore YV; Kuchekar BS; Late SG
    Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triamterene-beta-cyclodextrin systems: preparation, characterization and in vivo evaluation.
    Mukne AP; Nagarsenker MS
    AAPS PharmSciTech; 2004 Mar; 5(1):E19. PubMed ID: 15198540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
    Onyeji CO; Omoruyi SI; Oladimeji FA
    Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.